T-Cell Leukemia : : Characteristics, Treatment and Prevention / / Mariko Tomita, editor.
T-cell leukemia is relatively rare malignancy of thymocytes. There are around 20 entities and variants of this disease. Each of them has different characteristics, including pathogenesis, epidemiology, diagnosis, therapeutic approaches, and prognosis. Although T-cell leukemia is relatively rare mali...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | Rijeka, Croatia : : IntechOpen,, [2013] ©2013 |
Year of Publication: | 2013 |
Language: | English |
Physical Description: | 1 online resource (150 pages) :; illustrations |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993546074704498 |
---|---|
ctrlnum |
(CKB)4970000000098557 (NjHacI)994970000000098557 (oapen)https://directory.doabooks.org/handle/20.500.12854/66425 (EXLCZ)994970000000098557 |
collection |
bib_alma |
record_format |
marc |
spelling |
Tomita, Mariko edt T-Cell Leukemia : Characteristics, Treatment and Prevention / Mariko Tomita, editor. T-cell leukemia IntechOpen 2013 Rijeka, Croatia : IntechOpen, [2013] ©2013 1 online resource (150 pages) : illustrations text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022). Includes bibliographical references and index. T-cell leukemia is relatively rare malignancy of thymocytes. There are around 20 entities and variants of this disease. Each of them has different characteristics, including pathogenesis, epidemiology, diagnosis, therapeutic approaches, and prognosis. Although T-cell leukemia is relatively rare malignancy, many types of T-cell leukemias still have a very poor prognosis due to rapid progression. Therefore, the development of novel therapeutic and preventive strategies is necessary to improve prognosis. The purpose of this book is to provide a comprehensive overview of the disease from the basics of pathogenesis, epidemiology, morphology, and immunological features. This book also highlights the most recent achievements from basic and clinical researches including molecular mechanisms and novel therapies of T-cell leukemia. English T cells. Oncology 953-51-0996-0 Tomita, Mariko, editor. |
language |
English |
format |
eBook |
author2 |
Tomita, Mariko, |
author_facet |
Tomita, Mariko, |
author2_variant |
m t mt m t mt |
author2_role |
TeilnehmendeR |
title |
T-Cell Leukemia : Characteristics, Treatment and Prevention / |
spellingShingle |
T-Cell Leukemia : Characteristics, Treatment and Prevention / |
title_sub |
Characteristics, Treatment and Prevention / |
title_full |
T-Cell Leukemia : Characteristics, Treatment and Prevention / Mariko Tomita, editor. |
title_fullStr |
T-Cell Leukemia : Characteristics, Treatment and Prevention / Mariko Tomita, editor. |
title_full_unstemmed |
T-Cell Leukemia : Characteristics, Treatment and Prevention / Mariko Tomita, editor. |
title_auth |
T-Cell Leukemia : Characteristics, Treatment and Prevention / |
title_alt |
T-cell leukemia |
title_new |
T-Cell Leukemia : |
title_sort |
t-cell leukemia : characteristics, treatment and prevention / |
publisher |
IntechOpen IntechOpen, |
publishDate |
2013 |
physical |
1 online resource (150 pages) : illustrations |
isbn |
953-51-7097-X 953-51-0996-0 |
callnumber-first |
Q - Science |
callnumber-subject |
QR - Microbiology |
callnumber-label |
QR185 |
callnumber-sort |
QR 3185.8 T2 T345 42013 |
illustrated |
Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.079 |
dewey-sort |
3616.079 |
dewey-raw |
616.079 |
dewey-search |
616.079 |
work_keys_str_mv |
AT tomitamariko tcellleukemiacharacteristicstreatmentandprevention AT tomitamariko tcellleukemia |
status_str |
n |
ids_txt_mv |
(CKB)4970000000098557 (NjHacI)994970000000098557 (oapen)https://directory.doabooks.org/handle/20.500.12854/66425 (EXLCZ)994970000000098557 |
carrierType_str_mv |
cr |
is_hierarchy_title |
T-Cell Leukemia : Characteristics, Treatment and Prevention / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796649071877816321 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01043nam a2200301 i 4500</leader><controlfield tag="001">993546074704498</controlfield><controlfield tag="005">20221017132400.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">221017s2013 ci a ob 001 0 eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">953-51-7097-X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4970000000098557</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)994970000000098557</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/66425</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994970000000098557</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">QR185.8.T2</subfield><subfield code="b">.T345 2013</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.079</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Tomita, Mariko</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">T-Cell Leukemia :</subfield><subfield code="b">Characteristics, Treatment and Prevention /</subfield><subfield code="c">Mariko Tomita, editor.</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">T-cell leukemia</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">IntechOpen</subfield><subfield code="c">2013</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rijeka, Croatia :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">[2013]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">©2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (150 pages) :</subfield><subfield code="b">illustrations</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on: online resource; title from PDF information screen (InTech, viewed October 17, 2022).</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">T-cell leukemia is relatively rare malignancy of thymocytes. There are around 20 entities and variants of this disease. Each of them has different characteristics, including pathogenesis, epidemiology, diagnosis, therapeutic approaches, and prognosis. Although T-cell leukemia is relatively rare malignancy, many types of T-cell leukemias still have a very poor prognosis due to rapid progression. Therefore, the development of novel therapeutic and preventive strategies is necessary to improve prognosis. The purpose of this book is to provide a comprehensive overview of the disease from the basics of pathogenesis, epidemiology, morphology, and immunological features. This book also highlights the most recent achievements from basic and clinical researches including molecular mechanisms and novel therapies of T-cell leukemia.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">T cells.</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Oncology</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">953-51-0996-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tomita, Mariko,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-02-22 04:00:44 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-04-13 22:04:18 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338134970004498&Force_direct=true</subfield><subfield code="Z">5338134970004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338134970004498</subfield></datafield></record></collection> |